跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 52 条关于
“Antev”
全部
52
临床试验
33
药物
4
机构
1
资讯
14
去年
Medicus Pharma to Acquire Antev for $75 Million, Gaining Novel GnRH Antagonist for Prostate Conditions
7个月前
FDA Clears Phase 2b Trial of Teverelix for Advanced Prostate Cancer Patients with High Cardiovascular Risk
9个月前
Medicus Pharma Appoints Carolyn Bonner as CFO While Advancing Multiple Clinical Programs
8个月前
Medicus Pharma Secures Improved Teverelix License Terms and Reports Promising Phase 1 Data in Women
去年
Medicus Pharma Raises $11.2 Million to Advance Novel Microneedle Patch for Basal Cell Carcinoma Treatment
9个月前
Medicus Pharma Completes Phase 2 Enrollment for Novel Microneedle Basal Cell Carcinoma Treatment
3个月前
Medicus Pharma Submits IND for First-of-Its-Kind Genomics-Enabled Phase 2a Trial of Teverelix in Endometriosis
去年
Advanced Drug Delivery Technologies Drive Biotech Innovation as Nanomedicine Market Approaches $430 Billion
去年
Humacyte's ATEV Shows Promise in Clinical Trials, Driving Optimistic Market Outlook
去年
Humacyte's ATEV Awaits FDA Decision Amid Q3 2024 Financial Update
第 1 页,共 2 页
上一页
下一页